Charles River Laboratories (CRL) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

• Price: $175.42
• Market Cap: $8.25B
• EPS: $-1.52
• 52-Week High: $228.88
• 52-Week Low: $91.86

Market Sentiment

Charles River Laboratories currently has a Neutral sentiment score of 0.09.

About Charles River Laboratories

Charles River Laboratories International, Inc. (CRL) is a premier global provider of essential products and services tailored to the pharmaceutical, biotechnology, and medical device sectors. The company's expertise spans the entire drug development lifecycle, offering comprehensive preclinical and clinical laboratory services, as well as advanced gene and cell therapy solutions that enhance research and development efficiency. With a steadfast commitment to innovation and regulatory complian...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Charles River Laboratories and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRL pay dividends?

Charles River Laboratories (CRL) does not currently pay a regular dividend.

What is CRL's market cap?

Charles River Laboratories (CRL) has a market capitalization of $8.25B with a current stock price of $175.42.